479 related articles for article (PubMed ID: 22872307)
1. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
Tang Y; Ge J; Liu F; Wu P; Guo S; Liu Z; Wang Y; Wang Y; Ding Z; Wu J; Zuo C; Wang J
PLoS One; 2016; 11(4):e0152716. PubMed ID: 27064684
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
[TBL] [Abstract][Full Text] [Related]
5. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
Gasca-Salas C; Clavero P; García-García D; Obeso JA; Rodríguez-Oroz MC
Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
[TBL] [Abstract][Full Text] [Related]
6. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
[TBL] [Abstract][Full Text] [Related]
7. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH
Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071
[TBL] [Abstract][Full Text] [Related]
8. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
Firbank MJ; Yarnall AJ; Lawson RA; Duncan GW; Khoo TK; Petrides GS; O'Brien JT; Barker RA; Maxwell RJ; Brooks DJ; Burn DJ
J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):310-316. PubMed ID: 28315844
[TBL] [Abstract][Full Text] [Related]
9. [Statistical parametric mapping analysis of
Chu JS; Liu TH; Zang YZ; Wang KL; Ma HZ; Han CL; Zhao XB; Liu YP; Xia XT; Meng FG
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(33):2632-2635. PubMed ID: 30220149
[No Abstract] [Full Text] [Related]
10. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.
Hu MT; Taylor-Robinson SD; Chaudhuri KR; Bell JD; Labbé C; Cunningham VJ; Koepp MJ; Hammers A; Morris RG; Turjanski N; Brooks DJ
Brain; 2000 Feb; 123 ( Pt 2)():340-52. PubMed ID: 10648441
[TBL] [Abstract][Full Text] [Related]
11. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
12. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
13. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
[TBL] [Abstract][Full Text] [Related]
15. Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease.
De Rosa A; Peluso S; De Lucia N; Russo P; Annarumma I; Esposito M; Manganelli F; Brunetti A; De Michele G; Pappatà S
Parkinsonism Relat Disord; 2018 Feb; 47():80-83. PubMed ID: 29249679
[TBL] [Abstract][Full Text] [Related]
16. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
[TBL] [Abstract][Full Text] [Related]
17. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
Bohnen NI; Koeppe RA; Minoshima S; Giordani B; Albin RL; Frey KA; Kuhl DE
J Nucl Med; 2011 Jun; 52(6):848-55. PubMed ID: 21571793
[TBL] [Abstract][Full Text] [Related]
18. Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction.
Maier F; Greuel A; Hoock M; Kaur R; Tahmasian M; Schwartz F; Csoti I; Jessen F; Drzezga A; van Eimeren T; Timmermann L; Eggers C
Psychol Med; 2023 Mar; 53(4):1244-1253. PubMed ID: 37010224
[TBL] [Abstract][Full Text] [Related]
19. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
[TBL] [Abstract][Full Text] [Related]
20. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
